This inventor holds 3 USPTO granted patents. Top assignee: Teva Pharmaceutical Industries Limited. Active years: 2005-2008.
Company Filing History:
Years Active: 2005-2008
Title: Yigael Gozlan: Innovator in Pharmaceutical Patents
Introduction
Yigael Gozlan is a notable inventor based in Ramot Sapir, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his work on nateglinide, a medication used to treat type 2 diabetes. With a total of three patents to his name, Gozlan's innovations have the potential to impact the pharmaceutical industry significantly.
Latest Patents
Gozlan's latest patents focus on the polymorphic forms of nateglinide. He has developed various crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, O, P, Q, T, U, V, Y, α, β, γ, δ, ε, ζ, η, and ω. These patents detail the processes for their preparation and the methods for creating other crystalline forms of nateglinide. Additionally, Gozlan has provided pharmaceutical formulations and methods of administration for these forms, enhancing the therapeutic options available for patients.
Career Highlights
Yigael Gozlan is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His work at Teva has allowed him to focus on innovative solutions in drug formulation and delivery, contributing to the company's reputation for excellence in the pharmaceutical sector.
Collaborations
Gozlan has collaborated with notable colleagues, including Ronit Yahalomi and Evgeny Shapiro. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas within the pharmaceutical field.
Conclusion
Yigael Gozlan's contributions to the pharmaceutical industry through his patents on nateglinide exemplify the importance of innovation in healthcare. His work not only advances the science of drug formulation but also enhances patient care options.